CN Patent

CN117624139A — 二芳基类化合物及其制备方法和用途

Assigned to Wuhan Humanwell Innovative Drug Research and Development Center Ltd Co · Expires 2024-03-01 · 2y expired

What this patent protects

本发明公开了一种二芳基类化合物及其制备方法和用途。本发明的二芳基类化合物为如式I所示化合物或其药学上可接受的盐。所述化合物能够抑制人皮肤鳞状细胞癌细胞，具有较好的药代动力学性质，成药前景良好。

USPTO Abstract

本发明公开了一种二芳基类化合物及其制备方法和用途。本发明的二芳基类化合物为如式I所示化合物或其药学上可接受的盐。所述化合物能够抑制人皮肤鳞状细胞癌细胞，具有较好的药代动力学性质，成药前景良好。

Drugs covered by this patent

Patent Metadata

Patent number
CN117624139A
Jurisdiction
CN
Classification
—
Expires
2024-03-01
Drug substance claim
No
Drug product claim
No
Assignee
Wuhan Humanwell Innovative Drug Research and Development Center Ltd Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.